alovudine has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, C; Babusis, D; Hawkins, MJ; Henne, IN; Jeraj, R; Kurzman, ID; Lawrence, J; Plaza, S; Ray, AS; Reiser, H; Robat, C; Thamm, DH; Tumas, DB; Vail, DM; Vanderhoek, M; Watkins, WJ; Wessel, MA; Wolfgang, GH | 1 |
Buchmann, I; Neumaier, B; Reske, S; Schreckenberger, M | 1 |
2 other study(ies) available for alovudine and Diffuse Mixed Small and Large Cell Lymphoma
Article | Year |
---|---|
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
Topics: Alanine; Animals; Animals, Domestic; Anorexia; Antineoplastic Agents; Area Under Curve; Diarrhea; Dideoxynucleosides; Disease Models, Animal; Dog Diseases; Dogs; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Nausea; Positron-Emission Tomography; Purines; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2009 |
[18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study.
Topics: Adult; Aged; Dideoxynucleosides; Female; Fluorine Radioisotopes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals | 2004 |